Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Systemic therapy of breast cancer: practice guideline].
Horváth Z, Boér K, Dank M, Kahán Z, Kocsis J, Kövér E, Pajkos G, Pikó B, Rubovszky G, Eckhardt S. Horváth Z, et al. Magy Onkol. 2016 Sep;60(3):241-57. Epub 2016 Jul 14. Magy Onkol. 2016. PMID: 27579723 Free article. Review. Hungarian.
[Pharmaceutical therapy of breast cancer].
Láng I, Kahán Z, Pintér T, Dank M, Boér K, Pajkos G, Faluhelyi Z, Pikó B, Eckhardt S, Horváth Z. Láng I, et al. Among authors: horvath z. Magy Onkol. 2010 Sep;54(3):237-54. doi: 10.1556/MOnkol.54.2010.3.5. Magy Onkol. 2010. PMID: 20870601 Free article. Hungarian. No abstract available.
[Triple-negative breast carcinoma--rewiev of current literature].
Rubovszky G, Udvarhelyi N, Horváth Z, Láng I, Kásler M. Rubovszky G, et al. Among authors: horvath z. Magy Onkol. 2010 Dec;54(4):325-35. doi: 10.1556/MOnkol.54.2010.4.6. Magy Onkol. 2010. PMID: 21163763 Free article. Review. Hungarian.
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair machinery. Rubovszky G, Udvarhelyi N, Horvath Z, Lang I, Kasler M. Triple negative breast carcinoma - rewiev of current literature …
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair mach …
[Modern pharmacological therapy of breast cancer].
Láng I, Kahán Z, Hitre E, Dank M, Rubovszky G, Horváth Z, Kásler M. Láng I, et al. Among authors: horvath z. Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257. Orv Hetil. 2012. PMID: 22217685 Review. Hungarian.
[Systemic treatment of breast cancer: professional guideline].
Horváth Z, Boér K, Dank M, Kahán Z, Kocsis J, Kövér E, Máhr K, Pikó B, Rubovszky G. Horváth Z, et al. Magy Onkol. 2020 Dec 14;64(4):348-368. Epub 2020 Nov 30. Magy Onkol. 2020. PMID: 33313610 Free article. Hungarian.
Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.
Rubovszky G, Kocsis J, Boér K, Chilingirova N, Dank M, Kahán Z, Kaidarova D, Kövér E, Krakovská BV, Máhr K, Mriňáková B, Pikó B, Božović-Spasojević I, Horváth Z. Rubovszky G, et al. Among authors: horvath z. Pathol Oncol Res. 2022 Jul 11;28:1610383. doi: 10.3389/pore.2022.1610383. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35898593 Free PMC article.
454 results